Immutep Limited (ASX:IMM)
Australia · Delayed Price · Currency is AUD 0.3950
0.00 (0.00%)
At close: Dec 19, 2025
Immutep Market Cap
Immutep has a market cap or net worth of 582.12 million as of December 19, 2025. Its market cap has increased by 19.41% in one year.
Market Cap
582.12M
Enterprise Value
454.05M
Revenue
5.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.40
Market Cap Chart
Since August 29, 1996, Immutep's market cap has increased from 3.66M to 582.12M, an increase of 15,792.05%. That is a compound annual growth rate of 18.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 582.12M | 9.57% |
| Dec 31, 2024 | 531.29M | 29.54% |
| Dec 29, 2023 | 410.15M | 69.62% |
| Dec 30, 2022 | 241.81M | -42.22% |
| Dec 31, 2021 | 418.52M | 55.46% |
| Dec 31, 2020 | 269.22M | 166.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 84.46B |
| Pro Medicus | 22.71B |
| Cochlear | 16.85B |
| Sonic Healthcare | 11.16B |
| Ramsay Health Care | 7.96B |
| Ansell | 5.06B |
| Telix Pharmaceuticals | 4.01B |
| Mesoblast | 3.73B |